04/24/2024
6:30 AM | Charles River Laboratories International (Filer)
| Form DEFA14A | |
03/29/2024
7:00 AM | Charles River Laboratories International (Filer)
| Form DEF 14A | |
03/29/2024
7:01 AM | Charles River Laboratories International (Filer)
| Form ARS | |
03/25/2024
5:48 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4/A | |
03/25/2024
5:52 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4/A | |
03/25/2024
5:58 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4/A | |
03/25/2024
6:00 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4/A | |
|
03/25/2024
4:49 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4/A | |
03/25/2024
4:52 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4/A | |
03/25/2024
4:55 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4/A | |
03/11/2024
3:42 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
1:34 PM | Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
3:54 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
11:47 AM | Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:37 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
2:14 PM | Charles River Laboratories International (Subject)
Creamer Victoria L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
11:42 AM | Charles River Laboratories International (Subject)
Parisotto Shannon M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
3:57 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
10:09 AM | Barbo William D (Reporting)
Charles River Laboratories International (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
4:28 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:32 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:37 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
10:02 AM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
8:19 AM | Charles River Laboratories International (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
7:31 PM | Charles River Laboratories International (Issuer)
Kemps-Polanco Reshema (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:35 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:14 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:34 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4/A | |
01/31/2024
4:26 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:28 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:31 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:23 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:59 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:03 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:34 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SC 13G/A | |
01/16/2024
3:32 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
3:09 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:10 PM | Charles River Laboratories International (Subject)
Creamer Victoria L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
3:10 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
At first glance, this chart looks like nonsense… (Ad) We can isolate the most bullish dates to buy Netflix each and every year…
That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… |
11/30/2023
11:36 AM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
8:23 AM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
7:31 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
11:14 AM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023
8:06 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
3:23 PM | Charles River Laboratories International (Issuer)
WALLMAN RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
1:57 PM | Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
12:54 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023
8:09 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023
6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
3:37 PM | BlackRock Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SC 13G/A | |
07/05/2023
2:29 PM | Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
2:31 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
9:22 AM | Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
5:10 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
3:17 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
12:18 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
12:21 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
12:24 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
12:27 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
12:38 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
3:55 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
2:24 PM | Charles River Laboratories International (Issuer)
Thompson Craig B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
2:27 PM | Charles River Laboratories International (Issuer)
WILSON VIRGINIA M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:48 PM | Charles River Laboratories International (Issuer)
REESE C RICHARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:26 PM | Charles River Laboratories International (Issuer)
Kochevar Deborah Turner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:30 PM | Charles River Laboratories International (Issuer)
Llado George Sr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:43 PM | Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:46 PM | Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:11 PM | Andrews Nancy C (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:23 PM | BERTOLINI ROBERT J (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
1:18 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
3:02 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
1:42 PM | Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
1:49 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
1:20 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023
1:51 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/11/2023
8:08 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2023
7:00 AM | Charles River Laboratories International (Filer)
| Form DEFA14A | |
